Boston Trust Walden Corp Lowers Stock Holdings in Bio-Rad Laboratories, Inc. $BIO

Boston Trust Walden Corp decreased its position in shares of Bio-Rad Laboratories, Inc. (NYSE: BIO) by 5.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 89,838 shares of the medical research company's stock after selling 5,610 shares during the period. Boston